Parties d'ouvrages collectifs (1)
  1. 1. Ghanem, G. E., Loir, B., Pector, J. C., Ewalenko, P., Kerger, J., Fruhling, J., Lienard, D., Lejeune, F., & Deraemaecker, R. (1997). Evaluation of serum Protein S-100 as a new melanoma marker. In P. Altmeyer, K. Hoffman, & M. Stücker (Eds.), Skin cancer and UV radiation (pp. 1136-1144). Springer.
    2.   Articles dans des revues avec comité de lecture (7)
  2. 1. Ghanem, G. E., Loir, B., Morandini, R., Sales, F., Lienard, D., Eggermont, A., Lejeune, F., & EORTC Melanoma Group, (2001). On the release and half-life of S100B protein in the peripheral blood of melanoma patients. International journal of cancer, 94(4), 586-590. doi:10.1002/ijc.1504
  3. 2. Loir, B., Pérez Sánchez, C., Ghanem, G. E., Lozano, J. A., García-Borrón, J. C., & Jimenez-Cervantes Frigo, C. (1999). Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cellular and molecular biology, 45(7), 1083-1092.
  4. 3. Loir, B., Sales, F., Deraemaecker, R., Morandini, R., Garcia-Borron, J. C., & Ghanem, G. E. (1998). alpha-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis. European journal of cancer, 34(3), 424-426. doi:10.1016/S0959-8049(97)10016-8
  5. 4. Loir, B., Bouchard, B., Morandini, R., Del Marmol, V., Deraemaecker, R., Garcia-Borron, J. C., & Ghanem, G. E. (1997). Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells. European journal of biochemistry / FEBS, 244(3), 923-930.
  6. 5. Morandini, R., Süli-Vargha, H., Libert, A., Loir, B., Botyánszki, J., Medzihradszky, K., & Ghanem, G. E. (1994). Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line. International journal of cancer, 56(1), 129-133. doi:10.1002/ijc.2910560123
  7. 6. Ghanem, G. E., Loir, B., Hadley, M., Abdel Malek, Z., Libert, A., Del Marmol, V., Lejeune, F., Lozano, J., & García-Borron, J. C. (1992). Partial characterization of IR-alpha-MSH peptides found in melanoma tumors. Peptides, 13(5), 989-994. doi:10.1016/0196-9781(92)90060-G
  8. 7. Deschodt Lanckman, M., Vanneste, Y. G., Loir, B., Michel, A., Libert, A., Ghanem, G. E., & Lejeune, F. (1990). Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. International journal of cancer, 46(6), 1124-1130. doi:10.1002/ijc.2910460629
    9.   Thèses et mémoires (1)
  9. 1. Loir, B. (1997). Contribution à l'étude d'un peptide apparenté à l'alpha-mélanotropine dans le mélanome malin chez l'homme (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Médecine – Médecine, Bruxelles.